The role of the microbiota-gut-brain axis in methamphetamine-induced neurotoxicity: Disruption of microbial composition and short-chain fatty acid metabolism.

Lijian Chen, Kaikai Zhang, Jiali Liu, Xiuwen Li, Yi Liu, Hongsheng Ma, Jianzheng Yang, Jiahao Li, Long Chen, Clare Hsu, Jiahao Zeng, Xiaoli Xie, Qi Wang
Author Information
  1. Lijian Chen: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  2. Kaikai Zhang: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  3. Jiali Liu: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  4. Xiuwen Li: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  5. Yi Liu: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  6. Hongsheng Ma: Shunde Police in Foshan City, Foshan 528300, China.
  7. Jianzheng Yang: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  8. Jiahao Li: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  9. Long Chen: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  10. Clare Hsu: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  11. Jiahao Zeng: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.
  12. Xiaoli Xie: Department of Toxicology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou 510515, China.
  13. Qi Wang: Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China.

Abstract

methamphetamine (METH) abuse is associated with significant neurotoxicity, high addiction potential, and behavioral abnormalities. Recent studies have identified a connection between the gut microbiota and METH-induced neurotoxicity and behavioral disorders. However, the underlying causal mechanisms linking the gut microbiota to METH pathophysiology remain largely unexplored. In this study, we employed fecal microbiota transplantation (FMT) and antibiotic (Abx) intervention to manipulate the gut microbiota in mice administered METH. Furthermore, we supplemented METH-treated mice with short-chain fatty acids (SCFAs) and pioglitazone (Pio) to determine the protective effects on gut microbiota metabolism. Finally, we assessed the underlying mechanisms of the gut-brain neural circuit in vagotomized mice. Our data provide compelling evidence that modulation of the gut microbiome through FMT or microbiome knockdown by Abx plays a crucial role in METH-induced neurotoxicity, behavioral disorders, gut microbiota disturbances, and intestinal barrier impairment. Furthermore, our findings highlight a novel prevention strategy for mitigating the risks to both the nervous and intestinal systems caused by METH, which involves supplementation with SCFAs or Pio.

Keywords

References

  1. Acta Pharm Sin B. 2023 Oct;13(10):4202-4216 [PMID: 37799394]
  2. Microbiome. 2021 Mar 7;9(1):59 [PMID: 33678185]
  3. Neuropsychopharmacology. 2021 Nov;46(12):2062-2072 [PMID: 34127799]
  4. Clin Psychol Rev. 2021 Feb;83:101943 [PMID: 33271426]
  5. J Affect Disord. 2021 Mar 1;282:1120-1124 [PMID: 33601686]
  6. Toxicology. 2023 Mar 1;486:153447 [PMID: 36720452]
  7. Acta Pharm Sin B. 2023 Dec;13(12):4801-4822 [PMID: 38045052]
  8. Microorganisms. 2022 Dec 07;10(12): [PMID: 36557677]
  9. J Affect Disord. 2012 Jan;136(1-2):185-188 [PMID: 22036797]
  10. Acta Pharm Sin B. 2022 Aug;12(8):3281-3297 [PMID: 35967275]
  11. Microbiome. 2021 Jun 25;9(1):145 [PMID: 34172092]
  12. Redox Biol. 2023 Jun;62:102690 [PMID: 37018970]
  13. J Exerc Nutrition Biochem. 2018 Jun 30;22(2):1-6 [PMID: 30149419]
  14. J Ethnopharmacol. 2024 Mar 1;321:117489 [PMID: 38012973]
  15. Mol Psychiatry. 2018 Feb;23(2):467-475 [PMID: 27752079]
  16. Mol Biol Rep. 2023 Feb;50(2):1663-1675 [PMID: 36399245]
  17. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5 [PMID: 21876150]
  18. ACS Chem Neurosci. 2017 Mar 15;8(3):592-605 [PMID: 27977132]
  19. ACS Nano. 2023 Aug 8;17(15):15125-15145 [PMID: 37486121]
  20. Microbiome. 2021 Jan 31;9(1):34 [PMID: 33517890]
  21. Am J Public Health. 2023 Apr;113(4):416-419 [PMID: 36730885]
  22. Psychiatry Res Neuroimaging. 2022 Apr;321:111458 [PMID: 35152052]
  23. Pharmacol Res. 2017 Jun;120:60-67 [PMID: 28302577]
  24. Can J Psychiatry. 2023 Apr;68(4):249-256 [PMID: 36809914]
  25. Exp Neurol. 2021 Oct;344:113795 [PMID: 34186102]
  26. Cell. 2019 May 30;177(6):1600-1618.e17 [PMID: 31150625]
  27. Psychopharmacology (Berl). 2022 Dec;239(12):3875-3892 [PMID: 36282287]
  28. Surgery. 1958 Nov;44(5):854-9 [PMID: 13592638]
  29. Cell Rep. 2021 May 25;35(8):109163 [PMID: 34038733]
  30. Neuron. 2019 Mar 20;101(6):998-1002 [PMID: 30897366]
  31. BMC Gastroenterol. 2014 Nov 18;14:189 [PMID: 25407511]
  32. Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):461-478 [PMID: 31123355]
  33. Food Chem Toxicol. 2021 Feb;148:111946 [PMID: 33359793]
  34. Brain Res. 2018 Nov 1;1698:114-120 [PMID: 30077647]
  35. Mol Psychiatry. 2016 Jun;21(6):797-805 [PMID: 27090302]
  36. J Cereb Blood Flow Metab. 2023 May;43(5):791-800 [PMID: 36606600]
  37. Science. 2013 Aug 2;341(6145):569-73 [PMID: 23828891]
  38. Forensic Sci Res. 2022 May 31;7(4):736-747 [PMID: 36817241]
  39. Gut. 2020 Feb;69(2):283-294 [PMID: 31471351]
  40. Exp Mol Med. 2017 Aug 25;49(8):e370 [PMID: 28857085]
  41. J Autoimmun. 2021 Jan;116:102564 [PMID: 33203617]
  42. Neurosci Lett. 2018 Nov 20;687:22-25 [PMID: 30219487]
  43. Front Pharmacol. 2021 Jul 26;12:716703 [PMID: 34381368]
  44. Neurosci Lett. 2017 Feb 3;639:199-206 [PMID: 28063934]
  45. Cell Host Microbe. 2020 Aug 12;28(2):201-222 [PMID: 32791113]
  46. Neurosci Lett. 2021 Feb 16;746:135652 [PMID: 33482310]
  47. Cell Biochem Funct. 2017 Oct;35(7):472-476 [PMID: 29052243]
  48. World J Gastroenterol. 2017 Aug 14;23(30):5486-5498 [PMID: 28852308]
  49. PLoS One. 2016 Nov 16;11(11):e0166070 [PMID: 27851789]
  50. Acta Pharm Sin B. 2024 May;14(5):2057-2076 [PMID: 38799632]
  51. Microbiome. 2020 Aug 20;8(1):120 [PMID: 32819434]
  52. EMBO J. 2021 Sep 1;40(17):e106320 [PMID: 34260075]
  53. Gut. 2016 Nov;65(11):1906-1915 [PMID: 27531828]
  54. Front Microbiol. 2022 Apr 18;13:755189 [PMID: 35509309]
  55. Mol Psychiatry. 2020 May;25(5):1068-1079 [PMID: 30833676]
  56. Curr Opin Immunol. 2022 Jun;76:102177 [PMID: 35462279]
  57. Front Med (Lausanne). 2022 May 10;9:783121 [PMID: 35620725]
  58. Neurochem Res. 2022 Apr;47(4):872-884 [PMID: 34982394]
  59. Biomed Pharmacother. 2023 May;161:114478 [PMID: 37002574]
  60. Pharmacol Res. 2019 Oct;148:104403 [PMID: 31425750]
  61. Mol Psychiatry. 2023 Jul;28(7):3002-3012 [PMID: 37131071]
  62. BMJ Open. 2022 Oct 19;12(10):e062127 [PMID: 36261234]
  63. Biochem Biophys Res Commun. 2019 Feb 5;509(2):395-401 [PMID: 30594393]
  64. Nat Rev Microbiol. 2011 Apr;9(4):265-78 [PMID: 21407243]
  65. Microbiome. 2022 Apr 17;10(1):62 [PMID: 35430804]
  66. Diabetes. 2015 Jul;64(7):2398-408 [PMID: 25695945]
  67. Biomol Ther (Seoul). 2020 Sep 1;28(5):381-388 [PMID: 32668144]
  68. Drug Alcohol Rev. 2022 Jul;41(5):1041-1052 [PMID: 35604870]
  69. J Subst Use Addict Treat. 2023 Aug;151:209033 [PMID: 37011880]
  70. Handb Exp Pharmacol. 2014;220:461-79 [PMID: 24668483]
  71. Food Chem Toxicol. 2022 Aug;166:113208 [PMID: 35688268]
  72. Pharmacol Res. 2021 Oct;172:105840 [PMID: 34450312]
  73. Forensic Sci Res. 2023 Sep 04;8(3):173-184 [PMID: 38221972]
  74. Microbiome. 2019 Jun 29;7(1):98 [PMID: 31255176]
  75. Front Biosci (Landmark Ed). 2009 Jan 01;14(7):2765-78 [PMID: 19273235]
  76. Toxicol Appl Pharmacol. 2022 May 15;443:116011 [PMID: 35390362]
  77. PLoS One. 2013 Dec 23;8(12):e82847 [PMID: 24376593]
  78. Acta Pharm Sin B. 2022 Aug;12(8):3298-3312 [PMID: 35967282]
  79. Acta Pharm Sin B. 2023 May;13(5):2017-2038 [PMID: 37250149]

Word Cloud

Created with Highcharts 10.0.0microbiotagutMETHneurotoxicitybehavioraldisordersmicefattyMethamphetamineMETH-inducedunderlyingmechanismstransplantationFMTAbxFurthermoreshort-chainSCFAsPiometabolismmicrobiomeroleintestinalaxisacidabuseassociatedsignificanthighaddictionpotentialabnormalitiesRecentstudiesidentifiedconnectionHowevercausallinkingpathophysiologyremainlargelyunexploredstudyemployedfecalantibioticinterventionmanipulateadministeredsupplementedMETH-treatedacidspioglitazonedetermineprotectiveeffectsFinallyassessedgut-brainneuralcircuitvagotomizeddataprovidecompellingevidencemodulationknockdownplayscrucialdisturbancesbarrierimpairmentfindingshighlightnovelpreventionstrategymitigatingrisksnervoussystemscausedinvolvessupplementationmicrobiota-gut-brainmethamphetamine-inducedneurotoxicity:DisruptionmicrobialcompositionBehavioralFecalGutdysbiosisMicrobiota���gut���brainShort-chainVagotomyWnt/��-Catenin/GSK3��signalingpathway

Similar Articles

Cited By

No available data.